Overview
Yasushi Teshima practices in Oita, Japan. Teshima is rated as an Experienced expert by MediFind in the treatment of Heart Failure. Their top areas of expertise are Sick Sinus Syndrome, Atrial Fibrillation, Ventricular Fibrillation, Cardiac Ablation, and Percutaneous Coronary Intervention (PCI).
Their clinical research consists of co-authoring 76 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 9 articles in the study of Heart Failure.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Atrial FibrillationTeshima isAdvanced. Learn about Atrial Fibrillation.
- Brugada SyndromeTeshima isAdvanced. Learn about Brugada Syndrome.
- Coronary Artery SpasmTeshima isAdvanced. Learn about Coronary Artery Spasm.
- Heart BlockTeshima isAdvanced. Learn about Heart Block.
- Sick Sinus SyndromeTeshima isAdvanced. Learn about Sick Sinus Syndrome.
- Ventricular FibrillationTeshima isAdvanced. Learn about Ventricular Fibrillation.
- Experienced
- Acute Coronary SyndromeTeshima isExperienced. Learn about Acute Coronary Syndrome.
- AnginaTeshima isExperienced. Learn about Angina.
- Cardiac AblationTeshima isExperienced. Learn about Cardiac Ablation.
- CardiomyopathyTeshima isExperienced. Learn about Cardiomyopathy.
- Congenital Coronary Artery Malformation
- COVID-19Teshima isExperienced. Learn about COVID-19.